Moran Gadot
Tel Litwinsky, TA 52621, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Response to Anti-PD1/L1 Antibodies in Advanced Urothelial Cancer in the 'Real-Life' Setting.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 09, 2022
RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era.
Journal: Cancers
Published: May 28, 2022
Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell Carcinoma.
Journal: Cancers
Published: December 26, 2021
Immune checkpoint inhibitors-related encephalitis in melanoma and non-melanoma cancer patients: a single center experience.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 11, 2021
Patient and clinician experience with a rapidly implemented large-scale video consultation program during COVID-19.
Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care
Published: September 22, 2020
Associations between T cell infiltration, T cell receptor clonality, histology and recurrence in renal cell carcinoma.
Journal: Clinical and experimental immunology
Published: August 30, 2020
Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Journal: Breast cancer research : BCR
Published: March 14, 2020
Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer.
Journal: Cancers
Published: February 27, 2020
A Retrospective Analysis of the Safety and Activity of Lutetium-177-Prostate-Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal: The oncologist
Published: February 10, 2020
ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Journal: Breast cancer research : BCR
Published: September 01, 2019
Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort.
Journal: Breast (Edinburgh, Scotland)
Published: February 07, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026